Next-generation sequencing-based liquid biopsy may be used for detection of residual disease and cancer recurrence monitoring in dogs.
Angela L McCleary-WheelerPatrick C FiauxBrian K FlesnerCarlos A Ruiz-PerezLisa M McLennanJohn A TynanSusan C HicksJill M RafalkoDaniel S GrosuJason ChibukAllison L O'KellTodd A CohenIlya ChornyDana W Y TsuiKristina M KruglyakAndi FloryPublished in: American journal of veterinary research (2023)
Next-generation sequencing-based liquid biopsy is a noninvasive tool that may offer utility as an adjunct to current standard-of-care clinical assessment for cancer monitoring; further studies are needed to confirm diagnostic accuracy in a larger population.